» Articles » PMID: 29932645

Dissecting Substrate Specificities of the Mitochondrial AFG3L2 Protease

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2018 Jun 23
PMID 29932645
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Human AFG3L2 is a compartmental AAA+ protease that performs ATP-fueled degradation at the matrix face of the inner mitochondrial membrane. Identifying how AFG3L2 selects substrates from the diverse complement of matrix-localized proteins is essential for understanding mitochondrial protein biogenesis and quality control. Here, we create solubilized forms of AFG3L2 to examine the enzyme's substrate specificity mechanisms. We show that conserved residues within the presequence of the mitochondrial ribosomal protein, MrpL32, target the subunit to the protease for processing into a mature form. Moreover, these residues can act as a degron, delivering diverse model proteins to AFG3L2 for degradation. By determining the sequence of degradation products from multiple substrates using mass spectrometry, we construct a peptidase specificity profile that displays constrained product lengths and is dominated by the identity of the residue at the P1' position, with a strong preference for hydrophobic and small polar residues. This specificity profile is validated by examining the cleavage of both fluorogenic reporter peptides and full polypeptide substrates bearing different P1' residues. Together, these results demonstrate that AFG3L2 contains multiple modes of specificity, discriminating between potential substrates by recognizing accessible degron sequences and performing peptide bond cleavage at preferred patterns of residues within the compartmental chamber.

Citing Articles

Structural and mechanistic studies on human LONP1 redefine the hand-over-hand translocation mechanism.

Mindrebo J, Lander G bioRxiv. 2024; .

PMID: 38979310 PMC: 11230189. DOI: 10.1101/2024.06.24.600538.


Multifaceted Roles of AFG3L2, a Mitochondrial ATPase in Relation to Neurological Disorders.

Ghosh Dastidar R, Banerjee S, Lal P, Ghosh Dastidar S Mol Neurobiol. 2023; 61(7):3788-3808.

PMID: 38012514 PMC: 11236935. DOI: 10.1007/s12035-023-03768-z.


Novel compound heterozygous mutations in the gene in a Chinese child with microcephaly, early-onset seizures, and cerebral atrophy.

Jin T, Kuang Y, Luo S, Wang R, Chen K, Jiang M Heliyon. 2023; 9(4):e14766.

PMID: 37025825 PMC: 10070717. DOI: 10.1016/j.heliyon.2023.e14766.


AAA+ proteases: the first line of defense against mitochondrial damage.

Pareek G PeerJ. 2022; 10:e14350.

PMID: 36389399 PMC: 9648348. DOI: 10.7717/peerj.14350.


A novel mutation located in the intermembrane space domain of AFG3L2 causes dominant optic atrophy through decreasing the stability of the encoded protein.

Yang L, Jin X, Li Y, Guo Q, Yang M, You Y Cell Death Discov. 2022; 8(1):361.

PMID: 35970831 PMC: 9378676. DOI: 10.1038/s41420-022-01160-9.


References
1.
Leonhard K, Stiegler A, Neupert W, Langer T . Chaperone-like activity of the AAA domain of the yeast Yme1 AAA protease. Nature. 1999; 398(6725):348-51. DOI: 10.1038/18704. View

2.
Banfi S, Bassi M, Andolfi G, Marchitiello A, Zanotta S, Ballabio A . Identification and characterization of AFG3L2, a novel paraplegin-related gene. Genomics. 1999; 59(1):51-8. DOI: 10.1006/geno.1999.5818. View

3.
Orlowski M, Wilk S . Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys. 2000; 383(1):1-16. DOI: 10.1006/abbi.2000.2036. View

4.
de Kreij A, van den Burg B, Veltman O, Vriend G, Venema G, Eijsink V . The effect of changing the hydrophobic S1' subsite of thermolysin-like proteases on substrate specificity. Eur J Biochem. 2001; 268(18):4985-91. DOI: 10.1046/j.0014-2956.2001.02434.x. View

5.
Nishii W, Maruyama T, Matsuoka R, Muramatsu T, Takahashi K . The unique sites in SulA protein preferentially cleaved by ATP-dependent Lon protease from Escherichia coli. Eur J Biochem. 2002; 269(2):451-7. DOI: 10.1046/j.0014-2956.2001.02668.x. View